We are live on !
Find out more
FC
Fore Capital Portfolio holdings
AUM
$393M
Turnover
55.68%
1-Year Est. Return
3.68%
This Fund
S&P 500
This Quarter Est. Return
-1.13%
1 Year Est. Return
+3.68%
3 Year Est. Return
+24.29%
5 Year Est. Return
+22.77%
10 Year Est. Return
–
AUM
$393M
AUM Growth
+$54.2M
(+16%)
Cap. Flow
-$59.7M
Cap. Flow % of AUM
Cap. Flow %
-15.21%
Top 10 Holdings %
Top 10 Hldgs %
80.5%
Holding
88
New
21
Increased
7
Reduced
15
Closed
28
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.3
years
Top 20 Avg Time Held
Equity + Options
0.2
years
Avg Time Held Equity only
0.5
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.83M |
| 2 |
MakeMyTrip
MMYT
|
+$1.38M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$970K |
| 4 |
Nu Holdings
NU
|
+$851K |
| 5 |
First Trust Natural Gas ETF
FCG
|
+$590K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$10.5M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$2.22M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$1.21M |
| 4 |
KraneShares CSI China Internet ETF
KWEB
|
+$1.1M |
| 5 |
Annaly Capital Management
NLY
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.08% |
| 2 | Healthcare | 1.03% |
| 3 | Consumer Discretionary | 0.6% |
| 4 | Energy | 0.57% |
| 5 | Materials | 0.27% |
Similar funds
SC
WPI
Fore Capital's Q3 2026 Portfolio in Review
As of Q3 2026, Fore Capital held 88 positions worth $393M, up 16% from $338M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Fore Capital withdrew a net $59.7M in Q3 2026, closing 28 positions and reducing 15 holdings. Its most notable exit was VanEck Gold Miners ETF, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 97% of assets, up from 96% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fore Capital opened a new position in AstraZeneca worth $1.78M.
- Fore Capital's largest Q3 2026 buy was AstraZeneca: 11,000 shares worth $1.78M.
- Fore Capital added most to Evotec in Q3 2026, an estimated $39.6K increase.
- Fore Capital's biggest Q3 2026 reduction was EQT, cutting an estimated $943K.
- Fore Capital fully exited VanEck Gold Miners ETF in Q3 2026, selling an estimated $10.5M.
- Fore Capital's ten largest holdings make up 81% of its $393M portfolio in Q3 2026.
- Fore Capital opened 21 new positions and closed 28 in Q3 2026.
- Fore Capital's portfolio value rose 16% quarter-over-quarter to $393M.
Based on Fore Capital's 13F filing for Q3 2026, filed 13 Nov 2026.